To prospectively investigate the patterns and rates of progression of magnetic resonance (MR) imaging abnormalities in a well-documented cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) cohort 7 years after baseline and to identify the prognostic factors that determine the rates and patterns of this progression.
C
erebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a hereditary microangiopathy caused by mutations of the NOTCH3 gene. The microvascular changes are systemic, but the brunt of the abnormality affects the cerebral vasculature (1) . Clinical hallmarks are recurrent stroke, cognitive decline, migraine with aura (in up to 40% of patients), and mood disorders (in up to 30% of patients) (2) . Magnetic resonance (MR) imaging invariably reveals characteristic areas of white matter hyperintensity (WMH) with or without subcortical lacunar lesions (3), lacunar infarcts, and microbleeds in both symptomatic and asymptomatic adult human mutation carriers (4, 5) .
The results of various studies have established that MR imaging abnormalities in CADASIL are associated with clinical disease severity. Lacunar infarct and global brain atrophy were found to be associated with cognitive dysfunction (6, 7) , and WMH, lacunar infarct, microbleeding, and brain atrophy were found to be associated with physical disability (7) (8) (9) (10) . Cross-sectional studies have shown that the MR imaging abnormalities in CADASIL are also associated with cardiovascular risk factors, such as systolic blood pressure, hemoglobin A 1c level, sex, and age (4, 11) . The different MR imaging abnormalities are interrelated: The presence of a large number of microbleeds is associated with higher WMH and lacunar infarct volumes, whereas high lacunar infarct volume is associated with global brain atrophy (10, 12) . Because most studies for evaluating MR imaging lesions in CADASIL are cross-sectional, little is known about the long-term progression of MR imaging abnormalities or the prognostic risk factors associated with this progression. Two previously performed longitudinal MR imaging studies involved follow-ups of 2 years or less, without specific assessment of the prognostic risk factors (8, 13) . The aim of this study was to investigate the patterns and rates of progression of MR imaging abnormalities in a well-documented CADASIL cohort 7 years after baseline and to identify the prognostic factors that determine the rates and patterns of this progression.
Materials and Methods

Patients
Participants were recruited from a cross-sectional cohort of patients with CADASIL who were examined at baseline in 1999 and 2000 (4) . These patients, from 15 unrelated families, included 40 symptomatic and asymptomatic NOTCH3 gene mutation carriers and 22 non-mutation carriers. All participants were invited to undergo follow-up examinations. Interval deaths and reasons for not participating in the follow-up were recorded. Informed consent was obtained from the participants or from their family member(s) if the participant was unable to provide it. Exclusion criteria were age younger than 18 years at baseline, inability to provide confirmed consent at baseline, and/or any contraindication to MR imaging at baseline or follow-up. A total of 38 members from 12 unrelated families-25 mutation carriers and 13 non-mutation carriers-participated in the follow-up study. The non-mutation carriers served as control subjects because of the genetic and environmental backgrounds that they partially shared with mutation carriers from the same family. Approval for the study was obtained from the local medical ethics committee of Leiden University Medical Center.
The follow-up examinations were performed between November 2006 and September 2007. We obtained full medical histories of all participants and obtained medical records from their physicians and general practitioners. The following cardiovascular risk factors were determined: cigarette smoking history during the follow-up interval (in pack-years); history of hypertension, hypercholesterolemia, or diabetes mellitus; and migraine at baseline. Body mass index and presence or absence of apolipoprotein E genotype ε4 were also determined at baseline. Clinical and radiologic examinations were performed with blinding to the NOTCH3 mutation status.
MR Imaging
Image acquisition.-The same MR imaging protocol and the same 1.5-T MR sys-Ⅲ Lacunar infarcts, white matter hyperintensities, and microbleeds are progressive in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Ⅲ A higher load of MR imaging lesions at baseline is predictive of faster lesion progression at follow-up.
Implication for Patient Care
Ⅲ Since patients with a high MR imaging lesion load are at risk for faster progression of the disease, they may require more frequent clinical monitoring and MR imaging follow-up, whereas patients with a low lesion load at MR imaging may require less frequent monitoring. (14) . This software has been validated for lesion segmentation in elderly persons with WMHs. The WMHs in elderly individuals resemble the WMHs in patients with CADASIL (14) . Measurements were performed on dual spin-echo and fluid-attenuated inversion-recovery images.
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The intracranial volume was determined after skull stripping. The brain parenchyma and CSF were then segmented separately. Normalized brain volume, expressed as a percentage, was defined as the brain parenchyma volume relative to the total intracranial volume. We also divided the CSF volume into ventricular CSF volume and peripheral CSF volume. Manual correction steps were used between these steps to correct for random segmentation errors. These correction steps were performed by one observer (M.K.L., 5 years experience in cerebral MR imaging).
In the final segmentation step, the WMHs were segmented. WMHs were defined as areas of white matter with increased signal intensity on intermediate, T2-weighted, and fluid-attenuated inversion-recovery images. The segmentation software constructs an additional T2-weighted proton density image to distinguish the lesions from CSF. The WMH volume, expressed as a percentage, was corrected for total brain volume by dividing the individual volume of WMH by the total brain volume. In addition, the WMH volumes in each brain lobe were calculated by using predefined standard space masks.
The number and location of lacunar infarcts and the numbers of subcortical lacunar lesions and microbleeds were determined at a digital workstation by one observer (M.K.L.). A second observer (M.A.v.B., 15 years experience in cerebral MR imaging) reviewed the scores (ie, numbers of lacunar infarcts, subcortical lacunar lesions, and microbleeds), and in cases of conflicting scores, agreement was reached with a third observer (J.v.d.G., 15 years experience in cerebral MR imaging). All observers were blinded to the patient data. Images were scored in random order. Baseline and follow-up images were scored 4 months apart. After the lacunar infarcts were identified manually, they were marked on the MR image segmentations.
Lacunar infarcts were defined as parenchymal defects that had a diameter larger than 2 mm, had a signal intensity corresponding to that of CSF at all pulse sequences, and did not extend into the cortical gray matter (6) . Areas that were isointense to CSF at all pulse sequences, located in the lower third of the corpus striatum of the basal ganglia, and smaller than 2 mm in diameter were excluded from analysis so that lacunar infarcts could be differentiated from normal dilated perivascular spaces (15) .
Subcortical lacunar lesions were defined as linearly arranged groups of rounded, circumscribed lesions just below the cortex at the junction of the gray and white matter, with signal intensity identical to that of CSF on images obtained with all pulse sequences (3). Subcortical lacunar lesions were scored as present or absent.
Microbleeds were defined as focal areas of signal loss on T2-weighted spinecho images that were increased in size on T2*-weighted gradient-echo echoplanar images (blooming effect) (6) . This way, microbleeds could be differentiated from areas of signal loss caused by vascular flow voids. Areas of symmetric hypointensity in the basal ganglia that were likely to represent calcification or nonhemorrhagic iron deposits were excluded from analysis. Finally, to differentiate microbleeds from other intraaxial lesions with a hemorrhagic component, only those areas of signal loss that were not locally associated with other abnormalities were counted as microbleeds.
Visual mapping of WMHs and lacunar infarcts.-To visualize the distribution of WMHs and lacunar infarcts at baseline and follow-up, we created visual maps. These maps consisted of a set of sections that showed a summed distribution of all WMHs and lacunar infarcts throughout the brain in all of the mutation carriers. These maps were based on the segmentations of WMHs and lacunar infarcts performed by the segmentation software. The segmentation masks created by the software were first normalized to a standardized brain shape by using SPM-2 software (MATLAB Software Package Implementing Statistical Parametric Mapping for Neuroimaging Data, http://www.fil.ion.ucl.ac.uk/spm/spm2. html). This map creation step was needed to correct for differences in individual brain shapes and differences in head positioning during MR imaging. The normalized masks were then summed and projected onto a standardized brain shape to result in visual maps for baseline and follow-up. We subtracted the baseline visual maps from the follow-up visual maps to produce a visual map of the 7-year differences in WMHs and lacunar infarcts.
Statistical Analyses
Statistical analyses were performed by using the SPSS-14 statistical software package (SPSS, Chicago, Ill). Differences in demographic characteristics, cardiovascular risk factors, and MR imaging parameters between the NOTCH3 mutation carriers and the non-mutation carriers were analyzed by using parametric and nonparametric analyses of covariance (ANCOVA) for continuous variables and Cochran-Mantel-Haenszel 2 tests for categorical variables. To account for sources of correlation among observations within the same family, family identification number was used as a categorical covariate. In the comparisons of brain volume, ventricular volume, and peripheral CSF volume, age was used as a covariate to correct for possible age-related differences between the mutation carriers and non-mutation carriers. To identify the possible effects of selection bias on the study population, we also compared the baseline MR imaging parameters between the mutation carriers who did and those who did not provide follow-up data by using parametric and nonparametric ANCOVA, with family identification number as a categorical covariate.
To determine whether the distributions of WMHs and lacunar infarcts at baseline were age related, we used Spearman rank correlation coefficients for age with the WMH volume percentage and the lacunar infarct count in each brain sublocation. Changes in MR imaging parameters between baseline and follow-up were analyzed by using paired t, paired Wilcoxon, and McNemar tests. To determine whether the distributions of new WMHs and lacunar infarcts were different from the distributions of these abnormalities at baseline, we performed conditional logistic regression testing of lacunar infarct distributions with subject identification number as a covariate and performed mixed-model ANCOVA of the percentage increases in WMHs between the different brain regions with subject identification number as a random classification factor. Changes in MR imaging 
Results
Patients
Of the 62 original participants, seven died during the follow-up period, and 38 of the 55 remaining participants consented to participate in the follow-up study. Reasons for not participating were severe disease (n ϭ 3), disease-related immobility (n ϭ 2), hospital anxiety (n ϭ 2), and lack of interest or motivation (n ϭ 8). Two individuals did not provide a reason for their nonparticipation. Of the total of 24 subjects who did not participate, 15 were NOTCH3 mutation carriers. ANCOVA revealed that these mutation carriers had significantly more lacunar infarcts (P ϭ .001), microbleeds (P ϭ .03), and WMHs (P Ͻ .001) at baseline than did the mutation carriers who participated in the follow-up study.
Of the 38 participants in the follow-up study, 25 were NOTCH3 mutation carriers. The average time between the baseline and follow-up examinations was 7.1 years (range, 6.4 -7.7 years). Eight mutation carriers were asymptomatic at the baseline visit. The disease durations in the other mutation carriers were less than 5 years (five carriers), 5-10 years (five carriers), and 10 -21 years (seven carriers). There were no marked differences in sex, age, or cardiovascular risk factors between the mutation carriers and the non-mutation carriers (Table 1) .
MR Imaging Characteristics at Baseline and Follow-up
In the mutation carriers, the numbers of lacunar infarcts (P Ͻ .01), WMHs (P Ͻ .01), and microbleeds (P Ͻ .05) increased significantly between baseline and follow-up ( Table 2 ). The non-muta- 
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Liem et al tion carriers had no lacunar infarcts or microbleeds and no substantial amounts of WMHs at baseline or follow-up. At baseline, no significant differences in normalized brain volume, ventricular volume, or peripheral CSF volume were found between the mutation carriers and the non-mutation carriers. At follow-up, the mutation carriers had significant increases in ventricular volume (P Ͻ .01) and significant decreases in normalized brain volume (P Ͻ .05). At follow-up, the non-mutation carriers had decreases in normalized brain volume similar to those of the mutation carriers but no significant increases in ventricular volume. Figures 1 and 2 show the distributions of WMHs and lacunar infarcts that were present at baseline (Fig 1a) compared with the WMHs and lacunar infarcts that were new at follow-up (Fig 1b) . At baseline, the highest load of WMH lesions was found in the anterior temporal lobes and in the deep white matter of the frontal and parietal lobes. The occipital lobes were relatively spared, and virtually no lesions were found in the cerebellum. Sixty percent (872 mL/ 1446 mL) of the WMHs were located in the frontal lobes; 38% (546 mL/1446 mL), in the temporal and parietal lobes; and less than 2% (28 mL/1446 mL), in the occipital lobe and brainstem (Fig  2a) . Correlation testing revealed that this distribution of WMHs was independent of age. Figure 1b shows that the newly developed WMHs were distributed diffusely in all locations that were affected at baseline. Likewise, Figure 2b shows that the distribution of new WMHs between the brain lobes was virtually identical to the distribution of WMHs at baseline. These findings were confirmed at mixed-model ANCOVA testing. Figure 2c shows that the distribution of lacunar infarcts at baseline was different from the WMH distribution at baseline. The majority of lacunar infarcts were located in the basal ganglia and surrounding white matter areas. Figure 1a shows that in contrast to the 
Distribution of WMHs and Lacunar Infarcts
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distribution of WMHs, lacunar infarcts were relatively sparse in the anterior parts of the temporal lobes. Correlation testing of the lacunar infarct distribution at baseline revealed that higher age was associated with significantly more infarcts in the parietal lobe (P ϭ .03). The pie chart illustrating the distribution of new lacunar infarcts revealed that the percentage of parietally located lacunar infarcts was 11% higher than that at baseline. However, conditional logistic regression testing of the distribution of lacunar infarcts did not reveal any significant differences in distribution between the baseline and new infarcts.
Prognostic Risk Factors for Progression of MR Imaging Abnormalities
Neither age, sex, disease duration, nor any cardiovascular risk factor proved to be associated with the progression of any MR imaging parameter (Table 3) . A high load of WMH (P Ͻ .05), lacunar infarct (P Ͻ .001), and/or microbleed (P Ͻ .001) lesions at baseline was associated with a faster progression of these abnormalities. WMH volume at baseline enabled the prediction of lacunar infarct progression at follow-up (P Ͻ .01), and, conversely, lacunar infarct lesion load at baseline enabled the prediction of WMH volume progression at follow-up (P Ͻ .05). Subcortical lacunar lesions, normalized brain volume, ventricular volume, and peripheral CSF volume had no prognostic value in relation to any of the MR imaging parameters. Also, normalized brain volume at follow-up was not associated with any of the MR imaging parameters at baseline.
Discussion
The results of this longitudinal study show that lacunar infarcts, WMHs, and microbleeds are progressive in patients with CADASIL and that a higher load of these lesions at baseline is predictive of faster lesion progression at follow-up. The results also demonstrate that the progression of WMHs and lacunar infarcts has a distribution similar to the distribution of these parameters at baseline. While age and cardiovascular risk factor profile had no predictive value in terms of lesion progression, lesion load at baseline had predictive value in terms of lesion progression at follow-up: The higher the lesion load was at baseline, the greater the increase in number or extension of new lesions was at follow-up.
The longitudinal increase and distribution pattern of lacunar infarcts and microbleeds have not been well described in the literature. The increase in WMHs that we observed partially confirms the findings of the 2-year follow-up study of Peters et al (9) . We also found WMH volume at baseline to be predictive of the progression of both WMH volume and lacunar infarct lesion load at follow-up. Likewise, lacunar infarct lesion load at baseline was predictive of the progression of both lacunar infarct lesion load and WMH volume at followup. Microbleed count at baseline, however, was predictive of its own progression only and not of the progression of either WMH volume or lacunar infarct lesion load. The finding that progression of lacunar infarcts and progression of WMHs seem to be closely associated, but progression of microbleeds does not seem to be related to the progression of either of these abnormalities is interesting from a pathophysiologic point of view. It suggests that the vascular origin of WMHs and lacunar infarcts may be different from that of microbleeds in patients with CADASIL, even though these parameters are related to the same underlying disease. WMHs and lacunar infarcts are considered to be of ischemic origin, whereas microbleeds may result from vessel wall damage independent of ischemia, as suggested by the autopsy findings in a study of microbleeds in CADASIL (17) . Another finding that supports a distinct vascular origin of microbleeds is the reported different distribution of microbleeds compared with that of WMHs and lacunar infarcts (10) .
Our finding that the rate of brain volume loss is equal between mutation carriers and non-mutation carriers is in contrast to findings in the study of Peters et al, which suggest that global brain atrophy has an important role in CADASIL (9) . It is possible that our statistical analysis of whole brain volume was limited by the smaller sample size. However, an important advantage of our study is that we compared rates of brain volume loss progression in patients who had CADASIL with those in age-matched unaffected family members, whereas Peters et al compared atrophy rates in patients who had CADASIL with data reported in the literature. Our results suggest that brain atrophy is not part of the MR imaging spectrum of CADASIL.
This study had limitations. An overall drawback was the relatively small number of patients, which may have limited the statistical power of some of the correlation calculations. Another limitation was the group of 24 participants who were lost to follow-up, who included mutation carriers who died or were immobile because of severe disease. Statistical analyses revealed that the mutation carriers who were lost to follow-up had significantly more MR imaging abnormalities at baseline than did the mutation carriers who participated in the follow-up study. Therefore, our results are based primarily on the follow-up of patients who were relatively healthy at baseline, and, thus, they may not have provided an unbiased reflection of the patients with CADASIL in the original cohort. The strength of this study lies in its longitudinal design.
Finally, our findings have important implications for the counseling and treatment management of patients with CADASIL. A patient with a high MR imaging lesion load is at risk for faster progression of the disease and thus may require more frequent clinical monitoring and MR imaging follow-up, whereas a patient with a low lesion load at MR imaging probably has a relatively good prognosis for the next 5-10 years and may require less frequent monitoring. Patients with lacunar infarcts in particular should be monitored closely because lacunar infarcts are associated with disability and cognitive decline (6, 7 
